Publication Information

{'id': 'https://openalex.org/W2361900974', 'doi': None, 'title': 'Combination of diltiazem and losartan for treatment of mild to moderate primary hypertension', 'display_name': 'Combination of diltiazem and losartan for treatment of mild to moderate primary hypertension', 'publication_year': 2001, 'publication_date': '2001-01-01', 'ids': {'openalex': 'https://openalex.org/W2361900974', 'mag': '2361900974'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://en.cnki.com.cn/Article_en/CJFDTotal-XYYL2001S1001.htm', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764853906', 'display_name': 'Chinese Journal of New Drugs and Clinical Remedies', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/P4323986928', 'host_organization_name': 'Zhongguo Yao Xuehui Shanghai Fenhui', 'host_organization_lineage': ['https://openalex.org/P4323986928'], 'host_organization_lineage_names': ['Zhongguo Yao Xuehui Shanghai Fenhui'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': [], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5100308731', 'display_name': 'Yu Xie', 'orcid': 'https://orcid.org/0009-0005-1311-2356'}, 'institutions': [], 'countries': [], 'is_corresponding': True, 'raw_author_name': 'Xie Yu', 'raw_affiliation_strings': ['Cai,  ZHANG Feng  Ru,  LU Guo  Ping'], 'affiliations': [{'raw_affiliation_string': 'Cai,  ZHANG Feng  Ru,  LU Guo  Ping', 'institution_ids': []}]}], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': ['https://openalex.org/A5100308731'], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 59}, 'biblio': {'volume': None, 'issue': None, 'first_page': None, 'last_page': None}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10144', 'display_name': 'Blood Pressure and Hypertension Studies', 'score': 0.823, 'subfield': {'id': 'https://openalex.org/subfields/2705', 'display_name': 'Cardiology and Cardiovascular Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10144', 'display_name': 'Blood Pressure and Hypertension Studies', 'score': 0.823, 'subfield': {'id': 'https://openalex.org/subfields/2705', 'display_name': 'Cardiology and Cardiovascular Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11839', 'display_name': 'Hormonal Regulation and Hypertension', 'score': 0.7053, 'subfield': {'id': 'https://openalex.org/subfields/2712', 'display_name': 'Endocrinology, Diabetes and Metabolism'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/fosinopril', 'display_name': 'Fosinopril', 'score': 0.8604509}], 'concepts': [{'id': 'https://openalex.org/C2776741139', 'wikidata': 'https://www.wikidata.org/wiki/Q422229', 'display_name': 'Diltiazem', 'level': 3, 'score': 0.96441704}, {'id': 'https://openalex.org/C2780288358', 'wikidata': 'https://www.wikidata.org/wiki/Q410074', 'display_name': 'Losartan', 'level': 4, 'score': 0.8980022}, {'id': 'https://openalex.org/C2780436477', 'wikidata': 'https://www.wikidata.org/wiki/Q425293', 'display_name': 'Fosinopril', 'level': 4, 'score': 0.8604509}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.7640841}, {'id': 'https://openalex.org/C84393581', 'wikidata': 'https://www.wikidata.org/wiki/Q82642', 'display_name': 'Blood pressure', 'level': 2, 'score': 0.65876335}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.4779732}, {'id': 'https://openalex.org/C197934379', 'wikidata': 'https://www.wikidata.org/wiki/Q2047938', 'display_name': 'Adverse effect', 'level': 2, 'score': 0.44736552}, {'id': 'https://openalex.org/C126894567', 'wikidata': 'https://www.wikidata.org/wiki/Q105650', 'display_name': 'Urology', 'level': 1, 'score': 0.4201093}, {'id': 'https://openalex.org/C164705383', 'wikidata': 'https://www.wikidata.org/wiki/Q10379', 'display_name': 'Cardiology', 'level': 1, 'score': 0.39927605}, {'id': 'https://openalex.org/C2908929049', 'wikidata': 'https://www.wikidata.org/wiki/Q65963433', 'display_name': 'Angiotensin II', 'level': 3, 'score': 0.25604004}, {'id': 'https://openalex.org/C27016395', 'wikidata': 'https://www.wikidata.org/wiki/Q128861', 'display_name': 'Angiotensin-converting enzyme', 'level': 3, 'score': 0.1646077}, {'id': 'https://openalex.org/C519063684', 'wikidata': 'https://www.wikidata.org/wiki/Q706', 'display_name': 'Calcium', 'level': 2, 'score': 0.06077048}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://en.cnki.com.cn/Article_en/CJFDTotal-XYYL2001S1001.htm', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764853906', 'display_name': 'Chinese Journal of New Drugs and Clinical Remedies', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/P4323986928', 'host_organization_name': 'Zhongguo Yao Xuehui Shanghai Fenhui', 'host_organization_lineage': ['https://openalex.org/P4323986928'], 'host_organization_lineage_names': ['Zhongguo Yao Xuehui Shanghai Fenhui'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'score': 0.86, 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W3031348630', 'https://openalex.org/W2437413067', 'https://openalex.org/W2418936151', 'https://openalex.org/W2392795642', 'https://openalex.org/W2389642767', 'https://openalex.org/W2385462547', 'https://openalex.org/W2370336730', 'https://openalex.org/W2370042723', 'https://openalex.org/W2369117736', 'https://openalex.org/W2367900000', 'https://openalex.org/W2361401332', 'https://openalex.org/W2352157380', 'https://openalex.org/W2259334580', 'https://openalex.org/W2156485014', 'https://openalex.org/W2057545944', 'https://openalex.org/W2050239618', 'https://openalex.org/W2049703417', 'https://openalex.org/W2036091584', 'https://openalex.org/W1971607801', 'https://openalex.org/W1236481240'], 'abstract_inverted_index': {'AIM:': [0], 'To': [1], 'study': [2], 'the': [3, 82, 89, 94, 108, 131, 156, 162], 'efficacy': [4], 'and': [5, 9, 88, 117, 127, 135, 164, 173, 188], 'safety': [6, 90], 'of': [7, 15, 45, 65, 79, 84, 111, 161, 179], 'diltiazem': [8, 41, 51, 61, 70, 132, 172], 'losartan': [10, 43, 55, 134, 174], 'in': [11, 93, 124, 130, 159, 175], 'combination': [12, 176], 'for': [13, 177], 'treatment': [14, 101, 178], 'mild': [16, 180], 'to': [17, 181], 'moderate': [18, 182], 'primary': [19, 33, 183], 'hypertension.': [20], 'METHODS:': [21], 'In': [22], 'a': [23], 'randomized,': [24], 'single': [25], 'blind,': [26], 'parallel': [27], 'controlled': [28], 'study,': [29], '59': [30], 'patients': [31, 47, 67], 'with': [32, 50], 'hypertension': [34, 184], 'were': [35, 91, 115, 151], 'divided': [36], 'into': [37], 'two': [38, 95, 157], 'groups.': [39, 96], 'The': [40, 60, 77], 'plus': [42, 54, 62, 73, 133, 137, 170], 'group': [44, 64], '30': [46], 'was': [48, 68], 'treated': [49], '90': [52, 71], 'mg': [53, 57, 72], '50': [56], 'once': [58, 75], 'daily.': [59, 76], 'fosinopril': [63, 74], '29': [66], 'given': [69], 'reduction': [78], 'blood': [80], 'pressure(BP),': [81], 'improvement': [83], 'left': [85], 'ventricular': [86, 141], 'remodeling': [87], 'observed': [92], 'RESULTS:': [97], 'After': [98], '4': [99], 'wk,': [100, 107], 'BP': [102, 114, 120], 'reduced': [103], 'significantly.': [104], 'At': [105], '12': [106, 147], 'mean': [109], 'reductions': [110], 'systolic': [112], 'BP/diastolic': [113], '(2.1±0.3)/(2.1±0.4)kPa': [116], '(2.1±0.3)/(1.7±0.3)kPa,': [118], 'goal': [119], '(12.0/18.6': [121], 'kPa)': [122], 'achieved': [123], '83': [125], '%': [126, 129], '86': [128], 'ditiazem': [136, 169], 'fosinopril,': [138, 171], 'respectively.': [139], 'Left': [140], 'weight': [142], 'index': [143], 'decreased': [144], 'significantly': [145], 'after': [146], 'wk': [148], 'treatment.': [149], 'There': [150], 'not': [152], 'significant': [153], 'differences': [154], 'between': [155], 'groups': [158], 'all': [160], 'parameters': [163], 'adverse': [165], 'reactions.': [166], 'CONCLUSION:': [167], 'Like': [168], 'is': [185], 'effective,': [186], 'safe': [187], 'well': [189], 'tolerated.': [190]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2361900974', 'counts_by_year': [], 'updated_date': '2024-12-24T12:36:32.611467', 'created_date': '2016-06-24'}